Clinical Trials Search
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients
The purpose of this research study is to find out if information about a patient's genetic makeup (DNA) will help doctors better manage depression and anxiety symptoms.
Aim 1: Compare self-reported symptoms of depression and anxiety between DNA-guided or clinical management alone antidepressant prescribing strategies in cancer patients. Aim 2: Determine the impact DNA-guided choice of antidepressant has on quality of life in cancer patients.
> Patients with a cancer diagnosis.
> Patients not diagnosed with cancer